STING1 and neoplasm: Based on the analysis above, the present investigation endeavored to engineer a sophisticated targeted drug delivery platform capable of achieving triple therapeutic objectives: 1) precise tumor-specific drug delivery, 2) induction of tumor cell ferroptosis and ICD by oxidative cascades, and 3) potent activation of the STING pathway, thereby augmenting immunotherapeutic efficacy in cancer.